During 2019 , Belgium-based company Galapagos had an alliance with U.S. company Gilead Sciences and receivd an up-front payment of 4.5 billion U.S. dollars . This statistic depicts alliances formed involving biotech companies from the United States and/or Europe with large up-front payments .
